Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 115, 2009 - Issue 3
272
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Effects of AMPK activators on the sub-cellular distribution of fatty acid transporters CD36 and FABPpm

, , , , , , & show all
Pages 137-146 | Received 21 Aug 2008, Accepted 16 Apr 2009, Published online: 28 May 2009

References

  • Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. (1993). Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268:17665–8.
  • Bezaire V, Bruce CR, Heigenhauser GJ, Tandon NN, Glatz JF, Luiken JJ, Bonen A, Spriet LL. (2006). Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am J Physiol Endocrinol Metab 290:E509–15.
  • Bonen A, Chabowski A, Luiken JJ, Glatz JF. (2007). Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda) 22:15–29.
  • Bonen A, Luiken JJ, Arumugam Y, Glatz JF, Tandon NN. (2000). Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 275:14501–8.
  • Bradbury MW, Berk PD. (2000). Mitochondrial aspartate aminotransferase: direction of a single protein with two distinct functions to two subcellular sites does not require alternative splicing of the mRNA. Biochem J 345:423–7.
  • Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF, Bonen A. (2004). A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279:36235–41.
  • Chabowski A, Coort SL, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Bonen A. (2005). The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett 579:2428–32.
  • Chabowski A, Gorski J, Luiken JJ, Glatz JF, Bonen A. (2007). Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot Essent Fatty Acids 77:345–53.
  • Coburn CT, Knapp FF, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. (2000). Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275:32523–9.
  • Goodyear LJ, Hirshman MF, Horton ES. (1991). Exercise-induced translocation of skeletal muscle glucose transporters. Am J Physiol 261:E795–9.
  • Han XX, Chabowski A, Tandon NN, Calles-Escandon J, Glatz JF, Luiken JJ, Bonen A. (2007). Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle. Am J Physiol Endocrinol Metab 293:E566–75.
  • Harmon CM, Abumrad NA. (1993). Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 133:43–9.
  • Hawley SA, Gadalla AE, Olsen GS, Hardie DG. (2002). The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide- independent mechanism. Diabetes 51:2420–5.
  • Ibrahimi A, Bonen A, Blinn WD, Hajri T, Li X, Zhong K, Cameron R, Abumrad NA. (1999). Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 274:26761–6.
  • Jessen N, Goodyear LJ. (2005). Contraction signaling to glucose transport in skeletal muscle. J Appl Physiol 99:330–7.
  • Keizer HA, Schaart G, Tandon NN, Glatz JF, Luiken JJ. (2004). Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres. Histochem Cell Biol 121:101–7.
  • Kishi K, Yuasa T, Minami A, Yamada M, Hagi A, Hayashi H, Kemp BE, Witters LA, Ebina Y. (2000). AMP-activated protein kinase is activated by the stimulations of G(q)-coupled receptors. Biochem Biophys Res Commun 276:16–22.
  • Koonen DP, Glatz JF, Bonen A, Luiken JJ. (2005). Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta 1736:163–80.
  • Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW. (1999). 5’ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48:1667–71.
  • Luiken JJ, Coort SL, Koonen DP, van der Horst DJ, Bonen A, Zorzano A, Glatz JF. (2004). Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Arch 448:1–15.
  • Luiken JJ, Coort SL, Willems J, Coumans WA, Bonen A, van der Vusse GJ, Glatz JF. (2003). Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52:1627–34.
  • Luiken JJ, Turcotte LP, Bonen A. (1999). Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J Lipid Res 40:1007–16.
  • Muller H, Deckers K, Eckel J. (2002). The fatty acid translocase (FAT)/CD36 and the glucose transporter GLUT4 are localized in different cellular compartments in rat cardiac muscle. Biochem Biophys Res Commun 293:665–9.
  • Russell RR, Bergeron R, Shulman GI, Young LH. (1999). Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277:H643–9.
  • Samari HR, Seglen PO. (1998). Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase. J Biol Chem 273:23758–63.
  • Stremmel W, Strohmeyer G, Borchard F, Kochwa S, Berk PD. (1985). Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci USA 82:4–8.
  • Stump DD, Zhou SL, Berk PD. (1993). Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am J Physiol 265:G894–902.
  • van Dam KG, van Breda E, Schaart G, van Ginneken MM, Wijnberg ID, de Graaf-Roelfsema E, van der Kolk JH, Keizer HA. (2004). Investigation of the expression and localization of glucose transporter 4 and fatty acid translocase/CD36 in equine skeletal muscle. Am J Vet Res 65:951–6.
  • van Oort MM, van Doorn JM, Bonen A, Glatz JF, van der Horst DJ, Rodenburg KW, Luiken JJ. (2008). Insulin-induced translocation of CD36 to the plasma membrane is reversible and shows similarity to that of GLUT4. Biochim Biophys Acta 1781:61–71.
  • Vistisen B, Roepstorff K, Roepstorff C, Bonen A, van Deurs B, Kiens B. (2004). Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers. J Lipid Res 45:603–9.
  • Yang J, Holman GD. (2005). Insulin and contraction stimulate exocytosis, but increased AMP-activated protein kinase activity resulting from oxidative metabolism stress slows endocytosis of GLUT4 in cardiomyocytes. J Biol Chem 280:4070–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.